C12orf43-NAT10 Enhance breast cancer proliferation and chemotherapy resistance via BMI1-P53 signaling axis in a N4-acetylcytidine-dependent manner

ABSTRACT: C12orf43-NAT10 interaction was found to accelerate breast cancer progression and chemotherapy resistance by activating the BMI-P53 signaling axis in a N4-acetylcytidine-dependent manner.

ORGANISM(S): Homo sapiens

PROVIDER: GSE278114 | GEO | 2025/01/24

REPOSITORIES: GEO